These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10576617)

  • 21. Inhibition of cyclic AMP phosphodiesterase (PDE4) reverses memory deficits associated with NMDA receptor antagonism.
    Zhang HT; Crissman AM; Dorairaj NR; Chandler LJ; O'Donnell JM
    Neuropsychopharmacology; 2000 Aug; 23(2):198-204. PubMed ID: 10882846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protection by a cyclic AMP-specific phosphodiesterase inhibitor, rolipram, and dibutyryl cyclic AMP against Propionibacterium acnes and lipopolysaccharide-induced mouse hepatitis.
    Taguchi I; Oka K; Kitamura K; Sugiura M; Oku A; Matsumoto M
    Inflamm Res; 1999 Jul; 48(7):380-5. PubMed ID: 10450787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Noradrenaline modulates oyster hemocyte phagocytosis via a beta-adrenergic receptor-cAMP signaling pathway.
    Lacoste A; Malham SK; Cueff A; Poulet SA
    Gen Comp Endocrinol; 2001 Jun; 122(3):252-9. PubMed ID: 11356037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preventive but not therapeutic application of Rolipram ameliorates experimental autoimmune encephalomyelitis in Lewis rats.
    Jung S; Zielasek J; Köllner G; Donhauser T; Toyka K; Hartung HP
    J Neuroimmunol; 1996 Aug; 68(1-2):1-11. PubMed ID: 8784254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of eotaxin formation and eosinophil migration by selective inhibitors of phosphodiesterase type 4 isoenzyme.
    Silva PM; Alves AC; Serra MF; Pires AL; Silva JP; Barreto EO; Cordeiro RS; Jose PJ; Teixeira MM; Lagente V; Martins MA
    Br J Pharmacol; 2001 Sep; 134(2):283-94. PubMed ID: 11564646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-10 does not mediate the inhibitory effect of PDE-4 inhibitors and other cAMP-elevating drugs on lipopolysaccharide-induced tumors necrosis factor-alpha generation from human peripheral blood monocytes.
    Seldon PM; Barnes PJ; Giembycz MA
    Cell Biochem Biophys; 1998; 29(1-2):179-201. PubMed ID: 9631245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of cell adhesion molecule expression and function on human lung microvascular endothelial cells by inhibition of phosphodiesterases 3 and 4.
    Blease K; Burke-Gaffney A; Hellewell PG
    Br J Pharmacol; 1998 May; 124(1):229-37. PubMed ID: 9630364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rolipram attenuates bleomycin A5-induced pulmonary fibrosis in rats.
    Pan JB; Hou YH; Zhang GJ
    Respirology; 2009 Sep; 14(7):975-82. PubMed ID: 19740258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rolipram suppresses experimental autoimmune neuritis and prevents relapses in Lewis rats.
    Zou LP; Deretzi G; Pelidou SH; Levi M; Wahren B; Quiding C; van der Meide P; Zhu J
    Neuropharmacology; 2000 Jan; 39(2):324-33. PubMed ID: 10670428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergistic inhibition by beta(2)-agonists and corticosteroids on tumor necrosis factor-alpha-induced interleukin-8 release from cultured human airway smooth-muscle cells.
    Pang L; Knox AJ
    Am J Respir Cell Mol Biol; 2000 Jul; 23(1):79-85. PubMed ID: 10873156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of orally administered rolipram, a phosphodiesterase 4 inhibitor, on a mouse model of the dermatitis caused by 2,4,6-trinitro-1-chlorobenzene (TNCB)-repeated application.
    Harada D; Tsukumo Y; Takashima Y; Manabe H
    Eur J Pharmacol; 2006 Feb; 532(1-2):128-37. PubMed ID: 16442096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of inhibition of PDE4 and TNF-alpha on local and remote injuries following ischaemia and reperfusion injury.
    Souza DG; Cassali GD; Poole S; Teixeira MM
    Br J Pharmacol; 2001 Nov; 134(5):985-94. PubMed ID: 11682446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phosphodiesterase type 4 that regulates cAMP level in cortical neurons shows high sensitivity to rolipram.
    Yamashita N; Yamauchi M; Baba J; Sawa A
    Eur J Pharmacol; 1997 Oct; 337(1):95-102. PubMed ID: 9389386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rolipram, a specific type-4 phosphodiesterase inhibitor, inhibits cyclophosphamide-induced haemorrhagic cystitis in rats.
    Sakura M; Masuda H; Matsuoka Y; Yokoyama M; Kawakami S; Kihara K
    BJU Int; 2009 Jan; 103(2):264-9. PubMed ID: 18710439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of a phosphodiesterase IV inhibitor rolipram on microsphere embolism-induced defects in memory function and cerebral cyclic AMP signal transduction system in rats.
    Nagakura A; Niimura M; Takeo S
    Br J Pharmacol; 2002 Apr; 135(7):1783-93. PubMed ID: 11934820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional and biochemical evidence for diazepam as a cyclic nucleotide phosphodiesterase type 4 inhibitor.
    Collado MC; Beleta J; Martinez E; Miralpeix M; Domènech T; Palacios JM; Hernández J
    Br J Pharmacol; 1998 Mar; 123(6):1047-54. PubMed ID: 9559885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential regulation of human monocyte-derived TNF alpha and IL-1 beta by type IV cAMP-phosphodiesterase (cAMP-PDE) inhibitors.
    Verghese MW; McConnell RT; Strickland AB; Gooding RC; Stimpson SA; Yarnall DP; Taylor JD; Furdon PJ
    J Pharmacol Exp Ther; 1995 Mar; 272(3):1313-20. PubMed ID: 7891349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of selective phosphodiesterase inhibitors on the polymorphonuclear leukocyte respiratory burst.
    Nielson CP; Vestal RE; Sturm RJ; Heaslip R
    J Allergy Clin Immunol; 1990 Nov; 86(5):801-8. PubMed ID: 1977788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rolipram, a phosphodiesterase 4 inhibitor, prevented cancellous and cortical bone loss by inhibiting endosteal bone resorption and maintaining the elevated periosteal bone formation in adult ovariectomized rats.
    Yao W; Tian XY; Chen J; Setterberg RB; Lundy MW; Chmielzwski P; Froman CA; Jee WS
    J Musculoskelet Neuronal Interact; 2007; 7(2):119-30. PubMed ID: 17627081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of IL-15-stimulated TNF-alpha production by rolipram.
    Kasyapa CS; Stentz CL; Davey MP; Carr DW
    J Immunol; 1999 Sep; 163(5):2836-43. PubMed ID: 10453029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.